KIMS schedules analyst meeting in Mumbai on August 14

0 min read     Updated on 06 Jun 2026, 10:45 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Krishna Institute of Medical Sciences Limited has scheduled an Analyst and Institutional Investor Meeting on August 14, 2026, in Mumbai, as part of the Equirus Annual India Conference. The meeting will be conducted as a Group Meeting to discuss operations and strategy. The company confirmed that no unpublished price sensitive information will be shared.

powered bylight_fuzz_icon
42192668

*this image is generated using AI for illustrative purposes only.

Krishna Institute of Medical Sciences Limited has scheduled an Analyst and Institutional Investor Meeting on August 14, 2026, in Mumbai. The meeting is part of the Equirus Annual India Conference and will be conducted as a Group Meeting. This engagement provides a platform for the company to interact with analysts and institutional investors regarding its operations and strategy.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company clarified that no unpublished price sensitive information would be shared during the proceedings. The schedule remains subject to change due to exigencies.

Meeting Details

The following table outlines the specifics of the scheduled interaction:

Date of Meeting Event Venue Type of Meeting
August 14, 2026 Equirus Annual India Conference Mumbai, India Group Meeting

Nagajayanthi J.R, Company Secretary & Compliance Officer, signed the disclosure on June 5, 2026. The intimation was submitted to both the Bombay Stock Exchange Ltd (BSE) and the National Stock Exchange (NSE) for their information and records.

Historical Stock Returns for Krishna Institute of Medical Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
+3.14%+0.57%+15.48%+11.66%+18.02%+295.68%

What strategic initiatives or growth plans is KIMS likely to highlight during the meeting?

How might the engagement with institutional investors influence KIMS' stock performance in the short term?

What are the potential market reactions if KIMS hints at expansion or new partnerships during the conference?

Krishna Institute of Medical Sciences
View Company Insights
View All News
like20
dislike

Krishna Institute of Medical Sciences schedules analyst meet on Aug 13

0 min read     Updated on 03 Jun 2026, 12:49 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Krishna Institute of Medical Sciences Limited will host an analyst and institutional investor meeting on August 13, 2026, in Mumbai, as part of the JM Financial Centre Stage Conference. The company confirmed that no unpublished price sensitive information will be shared during the meeting, which is subject to change due to exigencies.

powered bylight_fuzz_icon
41952173

*this image is generated using AI for illustrative purposes only.

Krishna Institute of Medical Sciences Limited will host an analyst and institutional investor meeting on August 13, 2026, in Mumbai. The meeting, designated as the JM Financial Centre Stage Conference, is organized as a group meeting to engage with the investment community. The company stated that no unpublished price sensitive information would be shared during the proceedings.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The schedule is subject to change due to exigencies.

The meeting details are outlined below:

Date of Meeting Event Venue Type of Meeting
August 13, 2026 JM Financial Centre Stage Conference Mumbai, India Group Meeting

Krishna Institute of Medical Sciences Limited, headquartered in Secunderabad, operates through its registered office at D.No.: 1-8-31/1, Minister Road. The filing was digitally signed by Nagajayanthi J.R., Company Secretary & Compliance Officer.

Historical Stock Returns for Krishna Institute of Medical Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
+3.14%+0.57%+15.48%+11.66%+18.02%+295.68%

What strategic growth initiatives or expansion plans is KIMS likely to highlight for the post-2026 period?

How might management's commentary at the conference influence investor sentiment regarding the healthcare sector?

Could this meeting signal potential upcoming partnerships or M&A activity for the company?

Krishna Institute of Medical Sciences
View Company Insights
View All News
like17
dislike

More News on Krishna Institute of Medical Sciences

1 Year Returns:+18.02%